Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator. 2001

L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
S. C. Johnson Medical Research Center, Mayo Clinic Scottsdale, Scottsdale, Arizona 85259, USA.

After phosphorylation by protein kinase A, gating of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is regulated by the interaction of ATP with its nucleotide binding domains (NBDs). Models of this gating regulation have proposed that ATP hydrolysis at NBD1 and NBD2 may drive channel opening and closing, respectively (reviewed in Nagel, G. (1999) Biochim. Biophys. Acta 1461, 263-274). However, as yet there has been little biochemical confirmation of the predictions of these models. We have employed photoaffinity labeling with 8-azido-ATP, which supports channel gating as effectively as ATP to evaluate interactions with each NBD in intact membrane-bound CFTR. Mutagenesis of Walker A lysine residues crucial for azido-ATP hydrolysis to generate the azido-ADP that is trapped by vanadate indicated a greater role of NBD1 than NBD2. Separation of the domains by limited trypsin digestion and enrichment by immunoprecipitation confirmed greater and more stable nucleotide trapping at NBD1. This asymmetry of the two domains in interactions with nucleotides was reflected most emphatically in the response to the nonhydrolyzable ATP analogue, 5'-adenylyl-beta,gamma-imidodiphosphate (AMP-PNP), which in the gating models was proposed to bind with high affinity to NBD2 causing inhibition of ATP hydrolysis there postulated to drive channel closing. Instead we found a strong competitive inhibition of nucleotide hydrolysis and trapping at NBD1 and a simultaneous enhancement at NBD2. This argues strongly that AMP-PNP does not inhibit ATP hydrolysis at NBD2 and thereby questions the relevance of hydrolysis at that domain to channel closing.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000266 Adenylyl Imidodiphosphate 5'-Adenylic acid, monoanhydride with imidodiphosphoric acid. An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation. Adenyl Imidodiphosphate,gamma-Imino-ATP,AMP-PNP,AMPPNP,ATP(beta,gamma-NH),Adenosine 5'-(beta,gamma-Imino)triphosphate,Adenylimidodiphosphate,Adenylylimidodiphosphate,Mg AMP-PNP,Mg-5'-Adenylylimidodiphosphate,beta,gamma-imido-ATP,gamma-Imido-ATP,AMP-PNP, Mg,Imidodiphosphate, Adenyl,Imidodiphosphate, Adenylyl,Mg 5' Adenylylimidodiphosphate,Mg AMP PNP,beta,gamma imido ATP,gamma Imido ATP,gamma Imino ATP
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001386 Azides Organic or inorganic compounds that contain the -N3 group. Azide

Related Publications

L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
December 1999, Biochimica et biophysica acta,
L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
November 1998, The Journal of biological chemistry,
L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
January 1998, Methods in enzymology,
L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
April 1999, The Journal of biological chemistry,
L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
February 2005, Cellular and molecular life sciences : CMLS,
L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
July 1994, The Journal of clinical investigation,
L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
October 2008, The Journal of biological chemistry,
L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
October 2004, The Journal of biological chemistry,
L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
January 1995, The Journal of biological chemistry,
L Aleksandrov, and A Mengos, and X Chang, and A Aleksandrov, and J R Riordan
February 1991, Science (New York, N.Y.),
Copied contents to your clipboard!